Medicare Enrolled

Dr. Leroy Vaughn, M.D.

Ophthalmology · Inglewood, CA
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Low-engagement
323 N PRAIRIE AVE STE 217, Inglewood, CA 90301
3106710909
In practice since 2006 (19 years)
NPI: 1528149036 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Vaughn from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Vaughn? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Vaughn

Dr. Leroy Vaughn is an ophthalmology specialist in Inglewood, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Vaughn performed 6,396 Medicare services across 4,667 unique beneficiaries.

Between the years covered by Open Payments, Dr. Vaughn received a total of $7,466 from 21 pharmaceutical and/or device companies across 239 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in ophthalmology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Vaughn is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ Top 15% volume in CA $7,466 industry payments

Medicare Practice Summary

Medicare Utilization ↗
6,396
Medicare services
Top 15% in CA for ophthalmology
4,667
Unique beneficiaries
$75
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~337 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Comprehensive eye exam, established patient
A comprehensive examination of the visual system performed for a patient who has previously been seen by the provider.
2,647 $111 $176
Extended eye exam with retinal drawing
A detailed examination of the back of the eye that includes creating a drawing of the retina.
2,374 $21 $69
Comprehensive eye exam, new patient
A comprehensive examination of the visual system performed for a new patient.
605 $134 $208
Retinal photography (fundus photo)
This procedure involves taking photographs of the retina, the light-sensitive tissue at the back of the eye. It is used to document the condition of the eye's interior structures.
302 $31 $110
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
152 $111 $180
Visual field test, extended
A test that maps your complete field of vision to detect blind spots or peripheral vision loss. Extended testing provides a more detailed assessment than a standard visual field exam.
138 $55 $100
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
97 $133 $200
New patient office visit (30-44 min)
An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range.
67 $84 $200
Multiple eye pressure measurements over time
This procedure involves taking several measurements of the fluid pressure inside the eye across an extended period. It is used to monitor intraocular pressure levels.
14 $69 $100
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$7,466
Total received (2018-2024)
Avg $1,067/year across 7 years
Top 18% in CA for ophthalmology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
21
Companies
239
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$4,966 (66.5%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$2,500 (33.5%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$766
2023
$2,843
2022
$402
2021
$699
2020
$711
2019
$939
2018
$1,106

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$305
SUN PHARMACEUTICAL INDUSTRIES INC.
$216
Tarsus Pharmaceuticals, Inc.
$70
Alcon Vision LLC
$66
Amgen Inc.
$41
Dompe US, Inc.
$39
Oyster Point Pharma, Inc.
$29
Top 3 companies account for 77.2% of 2024 payments
All-time payments by company (2018-2024) ›
Partner Therapeutics, Inc.
$2,500
Allergan Inc.
$749
Allergan, Inc.
$711
Aerie Pharmaceuticals, Inc.
$697
Novartis Pharmaceuticals Corporation
$533
ABBVIE INC.
$381
Sun Pharmaceutical Industries Inc.
$362
Shire North American Group Inc
$282
SUN PHARMACEUTICAL INDUSTRIES INC.
$254
Bausch & Lomb, a division of Bausch Health US, LLC
$236
Alcon Vision LLC
$188
Oyster Point Pharma, Inc.
$136
Bausch & Lomb Americas Inc.
$82
AbbVie Inc.
$79
Tarsus Pharmaceuticals, Inc.
$70
Dompe US, Inc.
$62
Mallinckrodt Hospital Products Inc.
$53
Amgen Inc.
$41
Eyevance Pharmaceuticals LLC
$20
EYEVANCE PHARMACEUTICALS LLC
$16
Kala Pharmaceuticals, Inc.
$13
Top 3 companies account for 53.0% of all-time payments
Associated products mentioned in payments ›
ACTHAR · BROMSITE · BromSite (bromfenac ophthalmic solution) 0.075% · CEQUA · COMBIGAN · Cequa · DUREZOL · ILEVRO · INVELTYS · LEUKINE · LOTEMAX · LUMIGAN · MIEBO · OXERVATE · PROLENSA · RESTASIS · RESTASIS MULTIDOSE · Rhopressa · Rocklatan · TEPEZZA · TRAVATAN Z · TYRVAYA · TobraDex ST · Tobradex ST · VUITY · VYZULTA · XDEMVY · XELPROS · XIIDRA · rhopressa · rocklatan
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (66%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for an ophthalmology specialist in Inglewood?
Compare ophthalmologists in the Inglewood area by procedure volume, costs, and industry payment transparency.
Browse ophthalmologists nearby

Geographic Context

Ophthalmologists within 10 mi
758
Per 100K population
7.7
County median income
$87,760
Nearest hospital
CENTINELA HOSPITAL MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Vaughn is a mixed practice specialist, with above-average Medicare volume (top 15% in CA), with low-engagement industry engagement in the top 18% of CA peers, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Vaughn experienced with comprehensive eye exam, established patient?
Based on Medicare claims data, Dr. Vaughn performed 2,647 comprehensive eye exam, established patient services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Vaughn receive payments from pharmaceutical companies?
Yes. Dr. Vaughn received a total of $7,466 from 21 companies across 239 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Vaughn's costs compare to other ophthalmologists in Inglewood?
Dr. Vaughn's average Medicare payment per service is $75. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Vaughn) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →